Friday, October 30, 2009
Sunday, February 8, 2009
LI OCEANS bringing light to Ovarian Cancer
A Beacon of Hope for those affected by Ovarian Cancer...
LONG ISLAND OVARIAN CANCER EDUCATION ADVOCACY NETWORK SUPPORT.
Posted by
Khrissy Lupinacci
at
Sunday, February 08, 2009
Tuesday, April 22, 2008
Ovarian Cancer Grassroots Action Network-OCNA
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
BPA- inceases the risk for breast, ovarian and prostate cancer
The Canadian Federal government has announced its intention to ban the import and sale of plastic baby bottles containing bisphenol A. Several studies have found that the chemical, also known as BPA, can leach into a bottle's contents, increasing the risk for breast, ovarian and prostate cancer, even at low doses. A ban on BPA would make Canada the first country in the world to take such measures.
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant To Chemotherapy
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
Ovarian Cancer Stem Cells Identified, Characterized
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
More stores pull bisphenol A plastics from shelves
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
Toys 'R' Us to phase out bisphenol A baby bottles
Posted by
Khrissy Lupinacci
at
Tuesday, April 22, 2008
Monday, April 21, 2008
Surviving Cancer Doesn’t Lead to Healthier Lifestyle
Posted by
Khrissy Lupinacci
at
Monday, April 21, 2008
Friday, April 18, 2008
Bottle Maker to Stop Using Plastic Linked to Health Concerns
Posted by
Khrissy Lupinacci
at
Friday, April 18, 2008
Tuesday, March 25, 2008
Birth control pills' protection from ovarian cancer may last decades
Posted by
Khrissy Lupinacci
at
Tuesday, March 25, 2008
4th Annual Indian Island Charity Golf Outing
Sponsorships Opportunities
Dinner Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$1000.00
Beverage Golf Cart Sponsor
Dinner for 1 person
Promotional Sign on Beverage Cart
$250.00
Lunch Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00
Tee Sign Sponsor
Promotional sign on golf hole.
$100.00
Practice Range Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00
Putting Practice Green Sponsor
Promotional Sign/Banner in prominent Location
Recognition and Publicity in all pre/post events
Plus Tee Sign
$500.00
Other types of donations accepted:
Gift Certificates, Gift Baskets, Retail Items, Art, Memberships, etc..
Please write exactly what you would like your sign/banner to display:
Amount Enclosed $______________________
Send payment to Indian Island Country Club Att: Russ Moran:
(Make Checks Payable to Long Island Oceans)
Ph. 631-727-0788 Fax. 631-727-0861 http://www.indianislandcatering.com/
Indian Island Country Club
Posted by
Khrissy Lupinacci
at
Tuesday, March 25, 2008
Sunday, March 16, 2008
Monday, March 10, 2008
Global Montage of Special Ovarian Cancer Women
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Phenoxodiol Trials Highlighted at Ovarian Cancer Action International Conference
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Advanced-stage Ovarian Cancer Patients With BRCA Live Longer, May Respond Better To Treatment, Study Shows
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Advanced-stage Ovarian Cancer Patients With BRCA Live Longer, May Respond Better To Treatment, Study Shows
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
The second annual Johns Hopkins NanoBio Symposium will be held May 1-2, 2008 at the Johns Hopkins School of Medicine
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Recurrent Low-grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian Cancers
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1.
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Call on the House of Representatives to Fund Johanna's Law on Wednesday Call-in-Day Wednesday, March 12th for Johanna's Law Funding
Call on the House of Representatives to Fund Johanna's Law on Wednesday
Call-in-Day Wednesday, March 11 for Johanna's Law Funding
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Vermillion Reports Success of Ovarian Cancer Biomarker Panel
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Posted by
Khrissy Lupinacci
at
Monday, March 10, 2008
Thursday, March 6, 2008
NY-Times Cancer Funding: Does it add up?
March 6, 2008, 12:21 pm
Cancer Funding: Does It Add Up?
Should cancer spending be focused on the most common cancers? Or the most deadly cancers?
That’s the dilemma for the cancer research community as it struggles to divvy up limited funds. After news yesterday that actor Patrick Swayze had been diagnosed with pancreatic cancer, several readers questioned the nation’s cancer funding priorities. I decided to look at the numbers.
The National Cancer Institute spends about $6 billion a year in the war on cancer, allocating some funds for general cancer research and some for studies of specific cancers. But a review of the N.C.I.’s 2006 funding for five of the biggest cancers showed a wide disparity in the amounts of money spent relative to each cancer death and each new case of cancer. The data offer only a partial snapshot of public cancer spending in this country, as other government offices, such as the U.S. Department of Defense, also fund breast and prostate cancer research.
The big loser in the cancer funding race is lung cancer. It is the biggest cancer killer in the country, yet on a per-death basis receives the least N.C.I. funding among major cancers. In 2006, the N.C.I. spent $1,518 for each new case of lung cancer and $1,630 for each lung cancer death, according to data from the institute and the American Cancer Society.
Among the big cancers, breast cancer receives the most funding per new case, $2,596 — and by far the most money relative to each death, $13,452. Notably, prostate cancer, the most common cancer, receives the least funding per new case at just $1,318. But on a per-death basis it ranks second, with $11,298 in N.C.I. funds.
Here’s a look at the N.C.I. cancer funding based on 2006 death rates and incidence rates for some of the most common and deadliest cancers.
Cancer (Deaths)
N.C.I. Funding per Death
Lung (162,460)
$1,630
Colon (55,170)
$4,566
Breast (41,430)
$13,452
Pancreas (32,300 )
$2,297
Prostate (27,350)
$11,298
Cancer (New cases)
N.C.I. Funding per New Case
Prostate (234,460)
$1,318
Lung (174,470)
$1,518
Breast (214,640)
$2,596
Colon (106,680)
$2,361
Pancreas (33,730)
$2,200
Posted by
Khrissy Lupinacci
at
Thursday, March 06, 2008
Wednesday, March 5, 2008
New Ovarian Cancer Test Now Available in Europe
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Make Sure Your Representative Signs the Ovarian-Prostate Dear Colleague Letter
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
In vitro screening assay for detecting aromatase activity using rat ovarian microsomes and estrone ELISA
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Women With Undiagnosed Colorectal Adenocarcinomas Presenting With Ovarian Metastases: Clinicopathologic Features and Comparison With Women Having Know
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Plasma androgen concentrations and risk of incident ovarian cancer.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Migration deficit in monocyte-macrophages in human ovarian cancer.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cell
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
DeltaNp63 expression is associated with poor survival in ovarian cancer
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Amplification of 11q13 in ovarian carcinoma.
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Vitamin D: Cancer Prevention's Sunny Future?
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Protein That Fuels Ovarian Cancer Identified and Shut Down By Researchers
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Thalomid® Improves Response to Hycamtin® for Recurrent Ovarian Cancer
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
TAT 2008 6TH INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES
Posted by
Khrissy Lupinacci
at
Wednesday, March 05, 2008
Tuesday, March 4, 2008
Monday, February 18, 2008
Yale Test Detects Early Stage Ovarian Cancer With 99 Percent Accuracy
Posted by
Khrissy Lupinacci
at
Monday, February 18, 2008
Diagnostic Markers for Early Detection of Ovarian Cancer
Posted by
Khrissy Lupinacci
at
Monday, February 18, 2008
Friday, February 8, 2008
Charity Event to Break The Silence of Ovarian Cancer
Back In Motion ~ A Night Of Golden Memories"
CHARITY EVENT TO BREAK THE SILENCE OF OVARIAN CANCER
A fun-filled evening of networking, music, fine food, prizes and nostalgia will take place on April 1, 2008 from 6:00 P.M. – 10 P.M. at the Inn at New Hyde Park. The fundraising event is sponsored by Pro-fusion, home of the Long Island Breakfast Club, a career advocacy organization for mature professionals.
Posted by
Khrissy Lupinacci
at
Friday, February 08, 2008
Wednesday, December 12, 2007
LIPPzzzz -- Long Island Pajama Party- Girlz Night Out!
Huntington Hilton
7:00 PM - Midnight



